Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 USD | -11.50% | 0.00% | -94.87% |
Mar. 21 | Better Therapeutics, Inc. Receives Notice of Default from Hercules Capital, Inc | CI |
Mar. 20 | Better Therapeutics, Inc.(NasdaqCM:BTTX) dropped from S&P TMI Index | CI |
Financials (USD)
Sales 2023 * | - | Sales 2024 * | 3.8M | Capitalization | 545K |
---|---|---|---|---|---|
Net income 2023 * | -28M | Net income 2024 * | -47M | EV / Sales 2023 * | - |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 0.14 x |
P/E ratio 2023 * |
-0.01
x | P/E ratio 2024 * |
-0.01
x | Employees | 54 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 46.66% |
Latest transcript on Better Therapeutics, Inc.
1 day | -11.50% | ||
Current month | -23.08% | ||
1 month | +26.58% | ||
3 months | -94.75% | ||
6 months | -93.75% | ||
Current year | -94.87% |
Managers | Title | Age | Since |
---|---|---|---|
Andres Camacho
CTO | Chief Tech/Sci/R&D Officer | - | - |
Leslie Miller
AUD | Comptroller/Controller/Auditor | 43 | 21-09-30 |
Corporate Officer/Principal | - | 22-10-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 0.01 | -11.50% | 143,385 |
24-05-02 | 0.0113 | +0.36% | 181,459 |
24-05-01 | 0.0113 | -13.38% | 191,145 |
24-04-30 | 0.013 | +8.33% | 43,217 |
24-04-29 | 0.012 | +20.00% | 238,785 |
Delayed Quote OTC Markets, May 03, 2024 at 02:48 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-94.87% | 545K | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- BTTX Stock